NASDAQ: LOGC Shareholder Notice: Lawsuit Alleges Misleading Statements by LogicBio Therapeutics, Inc.
A lawsuit was filed on behalf of investors in LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares over alleged securities laws violations.
View full press release